Patent · US Active

Pyruvate kinase activators for use in therapy

US12377093B2 · kind B2 · utility

0Cited by
70References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 15, 2023
Grant dateAug 5, 2025
Priority date—
Expiry dateSep 15, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D307/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are methods for using compounds that activate pyruvate kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.